共 50 条
- [21] A phase 3 tRial comparing capecitabinE in combination with SorafenIb or pLacebo for treatment of locally advanced or metastatIc HER2-Negative breast CancEr (the RESILIENCE study): study protocol for a randomized controlled trialTRIALS, 2013, 14Baselga, JoseCosta, FredericoGomez, HenryHudis, Clifford A.Rapoport, BernardoRoche, HenriSchwartzberg, Lee S.Petrenciuc, OanaShan, MinghuaGradishar, William J.
- [22] A phase 3 tRial comparing capecitabinE in combination with SorafenIb or pLacebo for treatment of locally advanced or metastatIc HER2-Negative breast CancEr (the RESILIENCE study): study protocol for a randomized controlled trialTrials, 14José BaselgaFrederico CostaHenry GomezClifford A HudisBernardo RapoportHenri RocheLee S SchwartzbergOana PetrenciucMinghua ShanWilliam J Gradishar
- [23] Phase II Trial of Goserelin and Exemestane Combination Therapy in Premenopausal Women With Locally Advanced or Metastatic Breast CancerMEDICINE, 2015, 94 (26)Wang, JiayuXu, BingheYuan, PengMa, FeiLi, QingZhang, PinCai, RuigangFan, YingLuo, YangLi, Qiao
- [24] Fulvestrant for systemic therapy of locally advanced or metastatic breast cancer in postmenopausal women: a systematic reviewBreast Cancer Research and Treatment, 2009, 115Jennifer FlemmingYolanda MadarnasJacob A. Franek
- [25] Fulvestrant for systemic therapy of locally advanced or metastatic breast cancer in postmenopausal women: a systematic reviewBREAST CANCER RESEARCH AND TREATMENT, 2009, 115 (02) : 255 - 268Flemming, JenniferMadarnas, YolandaFranek, Jacob A.
- [26] Everolimus in Combination with Exemestane for Postmenopausal Women with Advanced Breast Cancer Who Are Refractory to Letrozole or Anastrozole: Results of the BOLERO-2 Phase III TrialEUROPEAN JOURNAL OF CANCER, 2011, 47 : 6 - +Baselga, J.Campone, M.Sahmoud, T.Piccart, M.Burris, H.Rugo, H.Noguchi, S.Gnant, M.Mukhopadhyay, P.Hortobagyi, G.
- [27] Expanded-Access Study of Palbociclib in Combination With Letrozole for Treatment of Postmenopausal Women With Hormone Receptor-Positive, HER2-Negative Advanced Breast CancerCLINICAL BREAST CANCER, 2018, 18 (06) : E1239 - E1245Stearns, VeredBrufsky, Adam M.Verma, ShailendraCotter, Matthew J.Lu, Dongrui R.Dequen, FlorenceJoy, Anil Abraham
- [28] Presurgical treatment with ribociclib and letrozole in patients with locally advanced breast cancer: The NEOLETRIB studyCANCER RESEARCH, 2022, 82 (04)Tekpli, XavierGoel, ShomHolm, BarbroFallang, Lars-EgilReitsma, Laurens CornelusGeisler, Stephanie BeateOdegard, Hilde PresterudFosskaug, Cathrine BergquistLindem, Ida CarolineSeyedzadeh, ManouchehrGeitung, Jonn TerjeReis, JoanaGjesdal, Kjell IngeBuvarp, Unn-CathrinLoeng, MarieSahlberg, Kristine KleiviPorojnicu, Alina CarmenSkjerven, Helle KristineTahiri, AndlienaJabeen, ShakilaLuders, TorbenBemanian, VahidJahnsen, JorgenLyngra, MarianneHurtado, AntoniCarroll, JasonChen, ShiuanKristensen, VesselaGeisler, Jurgen
- [30] BOLERO-2: EVEROLIMUS IN COMBINATION WITH EXEMESTANE IN THE TREATMENT OF POSTMENOPAUSAL WOMEN WITH ESTROGEN RECEPTOR-POSITIVE ADVANCED BREAST CANCER REFRACTORY TO LETROZOLE OR ANASTROZOLEBREAST, 2011, 20 : S30 - S30Campone, MarioPiccart, MartinePritchard, Kathleen I.Xu, CindyGnant, MichaelNeven, PatrickPistilli, BarbaraShtivelband, MikhailProvencher, LouiseMasuda, NorikazuEl-Hashimy, MonaVittori, LucSahmoud, TarekBaselga, JoseHortobagyi, Gabriel N.